Filter
83
Filtered Results: 83
Text search:
Clinical
and
Laboratory
Standards
Institute
(CLSI)
Featured
Recommendations
6
New Publications
13
Language
Document type
Studies & Reports
29
No document type
26
Guidelines
19
Strategic & Response Plan
5
Training Material
2
Situation Updates
2
Countries / Regions
India
5
Africa
4
Latin America and the Carribbean
4
Nigeria
3
Malawi
3
Western and Central Europe
3
Ethiopia
3
Ghana
2
Cameroon
2
Germany
2
Gabon
2
South Africa
2
Pakistan
2
Nepal
1
Kenya
1
Sierra Leone
1
China
1
Iran
1
Senegal
1
Burkina Faso
1
Peru
1
Zimbabwe
1
Philippines
1
Tanzania
1
Western Pacific Region
1
Bangladesh
1
Uganda
1
Zambia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Studies & Reports
19
General Guidelines
7
Guidelines
7
Drugs & Medical Equipment
5
Policies
4
Bacteriology
2
HIV & STI
2
Communicable Diseases
1
Community Health
1
Yersinia pestis (Plague)
1
Vaccine-preventable Diseases
1
Diarrhoeal Disease/Cholera
1
Medical Devices & Equipment
1
Policies & Guidelines HIV & TB
1
Parasitology
1
Key Resources
1
TB
1
Toolboxes
Country specific
23
Surveillance
11
Studies
5
International
4
Laboratory
3
Country Specific
3
Testing Guidelines
3
Rational use of Medicine
2
Pharmacovigilance
2
Antimicrobial Resistance (AMR)
2
General
2
Germany
2
Assessment
2
Clinical Aspects, Treatment & Prevention
1
Adults
1
Opportunistic Infections
1
Plague
1
Prevention Guidelines
1
Tools for Rational use
1
Laboratory & Sampling
1
Supporting tools
1
Health Personnel
1
General
1
Livestock production
1
Diagnostics & Laboratory Guidance
1
Clinical Guidelines
1
Essential Medicines & Devices Lists
1
General documents One Health
1
Water Pollution
1
Clinical Guidelines
1
Diarrhoea
1
Education of students & professionals
1
Stewardship
1
Clinical Guidelines
1
Western & Central Europe
1
TB
1
Plague Prevention & Control
1
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
Product:BDFACSCountTM InstrumentSystemwithFACSCountTM ControlKitandBD FACSCountTM CD4ReagentKit(AbsoluteandPercentageCD4+Counts)
Number: PQDx 0133-045-00
0133-045-00 WHO
PQDx PR
June/2016, version 2.0
des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP)
Recommendations for Diagnosis and Treatment of Nontuberculous Mycobacterioses of the German Central Committee against Tuberculosis and the German Respirator...
This core package of materials provides a comprehensive introduction to the FAST strategy: a focused approach to stopping TB spread in congregate settings. This core package is composed of a booklet, job aids, posters, and a button which serves as a visual reminder to staff and patients of the impor...
Manual for Early Implementation
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing ...
Antimicrobial resistance(AMR) poses a serious threat to human, animal and environmental health. Implementing ethical practice guidelines on how to use antimicrobials effectively and responsibly within the pig industry will contribute in reducing and preventing antimicro...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
Antimicrobial resistance (AMR) surveillance plays an important role in the early detection of resistant strains of public health importance and prompt response to outbreaks in hospitals and the community. Surveillance findings are needed to inform medical practice, antibiotic stewardship, and policy...
La vigilancia de la resistencia a los antimicrobianos (RAM) desempeña un papel importante en la detección temprana de cepas resistentes que revisten gran importancia para la salud pública, así como en la respuesta rápida a los brotes en los hospitales y en la comunidad. Los resultados de la vig...
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
